In a separate trial of CD19-CAR T cells in acute lymphoblastic leukemia (ALL) patients, two patients experienced CRS and for one patient this resulted in hospitalization on day 4 and transfer to intensive care on day 5 after the T-cell infusion (Grupp et al., 2013). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.